BMRN
BioMarin Pharmaceutical Inc.Healthcare$55.50
▲ Bullish
Mkt Cap: $10.67B|Float: 191.2M|SI: 4.4%|DTC: 3.9
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
24.1%
52W Range
$51-$70
ATR(14)
$1.66
Exp. Move
±6.2%
P/C Ratio
0.55
Earnings
Apr 30
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
BMRN Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $1.2M
- Max Pain
- $57.50
- Expected Move
- ±6.2%
- Put/Call OI
- 0.55
- Net Premium
- $0.1M
- Spot Price
- $55.50
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.45 | ±6.2% | $52.05 | $58.95 |
| 2026-05-15 | 43 | ±$7.03 | ±12.7% | $48.48 | $62.52 |
| 2026-07-17 | 106 | ±$10.40 | ±18.7% | $45.10 | $65.90 |
| 2026-08-21 | 141 | ±$11.80 | ±21.3% | $43.70 | $67.30 |
| 2026-10-16 | 197 | ±$5.50 | ±9.9% | $50.00 | $61.00 |
| 2027-01-15 | 288 | ±$14.60 | ±26.3% | $40.90 | $70.10 |
Explore BMRN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.